Please use this identifier to cite or link to this item:
https://doi.org/10.1155/2016/6120143
| Title: | Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization | Authors: | Ahmed, S De Souza, N.N Qiao, W Kasai, M Keem, L.J Shelat, V.G |
Issue Date: | 2016 | Publisher: | Hindawi Limited | Citation: | Ahmed, S, De Souza, N.N, Qiao, W, Kasai, M, Keem, L.J, Shelat, V.G (2016). Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. HPB Surgery 2016 : 6120143. ScholarBank@NUS Repository. https://doi.org/10.1155/2016/6120143 | Rights: | Attribution 4.0 International | Abstract: | Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients. © 2016 Saleem Ahmed et al. | Source Title: | HPB Surgery | URI: | https://scholarbank.nus.edu.sg/handle/10635/179619 | ISSN: | 0894-8569 | DOI: | 10.1155/2016/6120143 | Rights: | Attribution 4.0 International |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| 10_1155_2016_6120143.pdf | 1.37 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License
